These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 25088040)

  • 1. Arsenic trioxide exerts anti-lung cancer activity by inhibiting angiogenesis.
    Yang MH; Zang YS; Huang H; Chen K; Li B; Sun GY; Zhao XW
    Curr Cancer Drug Targets; 2014; 14(6):557-66. PubMed ID: 25088040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arsenic Trioxide Suppresses Tumor Growth through Antiangiogenesis via Notch Signaling Blockade in Small-Cell Lung Cancer.
    Yang MH; Chang KJ; Li B; Chen WS
    Biomed Res Int; 2019; 2019():4647252. PubMed ID: 31093499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulfated fucoidan FP08S2 inhibits lung cancer cell growth in vivo by disrupting angiogenesis via targeting VEGFR2/VEGF and blocking VEGFR2/Erk/VEGF signaling.
    Chen H; Cong Q; Du Z; Liao W; Zhang L; Yao Y; Ding K
    Cancer Lett; 2016 Nov; 382(1):44-52. PubMed ID: 27569654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Barbigerone, an isoflavone, inhibits tumor angiogenesis and human non-small-cell lung cancer xenografts growth through VEGFR2 signaling pathways.
    Li X; Wang X; Ye H; Peng A; Chen L
    Cancer Chemother Pharmacol; 2012 Sep; 70(3):425-37. PubMed ID: 22814678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of TGF-β/SMAD3/NF-κB signaling by microRNA-491 is involved in arsenic trioxide-induced anti-angiogenesis in hepatocellular carcinoma cells.
    Jiang F; Wang X; Liu Q; Shen J; Li Z; Li Y; Zhang J
    Toxicol Lett; 2014 Nov; 231(1):55-61. PubMed ID: 25196641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor and antiangiogenic effects of GA-13315, a gibberellin derivative.
    Zhang Y; Zhang H; Chen J; Zhao H; Zeng X; Zhang H; Qing C
    Invest New Drugs; 2012 Feb; 30(1):8-16. PubMed ID: 20711631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tanshinone IIA inhibits β-catenin/VEGF-mediated angiogenesis by targeting TGF-β1 in normoxic and HIF-1α in hypoxic microenvironments in human colorectal cancer.
    Sui H; Zhao J; Zhou L; Wen H; Deng W; Li C; Ji Q; Liu X; Feng Y; Chai N; Zhang Q; Cai J; Li Q
    Cancer Lett; 2017 Sep; 403():86-97. PubMed ID: 28602978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of arsenic trioxide on vascular endothelial cell proliferation and expression of vascular endothelial growth factor receptors Flt-1 and KDR in gastric cancer in nude mice.
    Xiao YF; Wu DD; Liu SX; Chen X; Ren LF
    World J Gastroenterol; 2007 Dec; 13(48):6498-505. PubMed ID: 18161919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular and functional evaluation of a novel HIF inhibitor, benzopyranyl 1,2,3-triazole compound.
    Park K; Lee HE; Lee SH; Lee D; Lee T; Lee YM
    Oncotarget; 2017 Jan; 8(5):7801-7813. PubMed ID: 27999195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-talk between endothelial cells and tumor via delta-like ligand 4/Notch/PTEN signaling inhibits lung cancer growth.
    Ding XY; Ding J; Wu K; Wen W; Liu C; Yan HX; Chen C; Wang S; Tang H; Gao CK; Guo LN; Cao D; Li Z; Feng GS; Wang HY; Xu ZF
    Oncogene; 2012 Jun; 31(23):2899-906. PubMed ID: 22002304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
    Chen MC; Lee CF; Huang WH; Chou TC
    Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bevacizumab radiosensitizes non-small cell lung cancer xenografts by inhibiting DNA double-strand break repair in endothelial cells.
    Gao H; Xue J; Zhou L; Lan J; He J; Na F; Yang L; Deng L; Lu Y
    Cancer Lett; 2015 Aug; 365(1):79-88. PubMed ID: 25982206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic anticancer effects of ginsenoside CK and gefitinib against gefitinib-resistant NSCLC by regulating the balance of angiogenic factors through HIF-1α/VEGF.
    Song X; Wang L; Cai P; Xu Y; Liu Q; Fan D
    Toxicol Appl Pharmacol; 2024 May; 486():116938. PubMed ID: 38642809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antihypertension drug doxazosin inhibits tumor growth and angiogenesis by decreasing VEGFR-2/Akt/mTOR signaling and VEGF and HIF-1α expression.
    Park MS; Kim BR; Dong SM; Lee SH; Kim DY; Rho SB
    Oncotarget; 2014 Jul; 5(13):4935-44. PubMed ID: 24952732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual blockade of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (FGF-2) exhibits potent anti-angiogenic effects.
    Li D; Xie K; Zhang L; Yao X; Li H; Xu Q; Wang X; Jiang J; Fang J
    Cancer Lett; 2016 Jul; 377(2):164-73. PubMed ID: 27130666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-206 attenuates the growth and angiogenesis in non-small cell lung cancer cells by blocking the 14-3-3ζ/STAT3/HIF-1α/VEGF signaling.
    Xue D; Yang Y; Liu Y; Wang P; Dai Y; Liu Q; Chen L; Shen J; Ju H; Li Y; Tan Z
    Oncotarget; 2016 Nov; 7(48):79805-79813. PubMed ID: 27806334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An-te-xiao capsule inhibits tumor growth in non-small cell lung cancer by targeting angiogenesis.
    Han L; Wang JN; Cao XQ; Sun CX; Du X
    Biomed Pharmacother; 2018 Dec; 108():941-951. PubMed ID: 30372906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arsenic Trioxide Suppresses Angiogenesis in Non-small Cell Lung Cancer
    Wang M; Yin J; Han Q; Li B; Zhao XW; Xue L
    Anticancer Agents Med Chem; 2024; 24(15):1142-1150. PubMed ID: 38847245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Realgar transforming solution suppresses angiogenesis and tumor growth by inhibiting VEGF receptor 2 signaling in vein endothelial cells.
    Song P; Hai Y; Wang X; Zhao L; Chen B; Cui P; Xie Q; Yu L; Li Y; Wu Z; Li H
    Arch Pharm Res; 2018 Apr; 41(4):467-480. PubMed ID: 29542005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
    Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
    Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.